Metagenomi, Inc.

The momentum for this stock is not very good. Metagenomi, Inc. is not a good growth stock. Metagenomi, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Metagenomi, Inc..
Log in to see more information.

News

Financial Contrast: Metagenomi (NASDAQ:MGX) and Agenus (NASDAQ:AGEN)
Financial Contrast: Metagenomi (NASDAQ:MGX) and Agenus (NASDAQ:AGEN)

Ticker Report Metagenomi (NASDAQ:MGX - Get Free Report) and Agenus (NASDAQ:AGEN - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based...\n more…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc. - MGX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc. - MGX

PR Newswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc. - MGX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...\n more…

Metagenomi, Inc. (NASDAQ:MGX) CFO Pamela Wapnick Sells 6,265 Shares
Metagenomi, Inc. (NASDAQ:MGX) CFO Pamela Wapnick Sells 6,265 Shares

Zolmax Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) CFO Pamela Wapnick sold 6,265 shares of the business's stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of...\n more…

Pamela Wapnick Sells 6,265 Shares of Metagenomi, Inc. (NASDAQ:MGX) Stock
Pamela Wapnick Sells 6,265 Shares of Metagenomi, Inc. (NASDAQ:MGX) Stock

Ticker Report Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) CFO Pamela Wapnick sold 6,265 shares of Metagenomi stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of...\n more…

Metagenomi (NASDAQ:MGX) Rating Reiterated by Chardan Capital
Metagenomi (NASDAQ:MGX) Rating Reiterated by Chardan Capital

Ticker Report Metagenomi (NASDAQ:MGX - Get Free Report)s stock had its "buy" rating reiterated by Chardan Capital in a research report issued to clients and investors on Thursday, Benzinga reports. They...\n more…

Peeling Back The Layers: Exploring Metagenomi Through Analyst Insights
Peeling Back The Layers: Exploring Metagenomi Through Analyst Insights

Benzinga 6 analysts have shared their evaluations of Metagenomi MGX during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.\n more…